| Kara Kristin Cooper-gilmer, FNP | |
|
2000 E Greenville St Ste 2800, Anderson, SC 29621-1722 | |
| (864) 512-7636 | |
| (864) 512-3641 |
| Full Name | Kara Kristin Cooper-gilmer |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 2000 E Greenville St Ste 2800, Anderson, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437387354 | NPI | - | NPPES |
| NP1693 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 3911 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Anmed Health | Anderson, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anmed Health | 1951215243 | 276 |
News Archive
Researchers at Caltech have developed a prototype miniature medical device that could ultimately be used in "smart pills" to diagnose and treat diseases.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
In a new study posted to the bioRxiv* preprint server, a prospective cohort of patients with COVID-19 exhibited distinct features of the IgG fragment antigen-binding (Fab) and fragment crystallizable (Fc) domains, predicting two distinct disease trajectory two days after a positive test.
The media should contribute to addressing tuberculosis in Ghana by disseminating information about TB transmission and encouraging the public to attend screenings, Frank Bonsu, program manager for the country's National Tuberculosis Control Program, said recently, Ghana Broadcasting Corporation reports. Bonsu spoke during a one-day TB advocacy workshop for media at the Korle-Bu Teaching Hospital in Accra.
› Verified 3 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710918321 PECOS PAC ID: 1951215243 Enrollment ID: O20031119000738 |
News Archive
Researchers at Caltech have developed a prototype miniature medical device that could ultimately be used in "smart pills" to diagnose and treat diseases.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
In a new study posted to the bioRxiv* preprint server, a prospective cohort of patients with COVID-19 exhibited distinct features of the IgG fragment antigen-binding (Fab) and fragment crystallizable (Fc) domains, predicting two distinct disease trajectory two days after a positive test.
The media should contribute to addressing tuberculosis in Ghana by disseminating information about TB transmission and encouraging the public to attend screenings, Frank Bonsu, program manager for the country's National Tuberculosis Control Program, said recently, Ghana Broadcasting Corporation reports. Bonsu spoke during a one-day TB advocacy workshop for media at the Korle-Bu Teaching Hospital in Accra.
› Verified 3 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639102270 PECOS PAC ID: 1951215243 Enrollment ID: O20040130000302 |
News Archive
Researchers at Caltech have developed a prototype miniature medical device that could ultimately be used in "smart pills" to diagnose and treat diseases.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
In a new study posted to the bioRxiv* preprint server, a prospective cohort of patients with COVID-19 exhibited distinct features of the IgG fragment antigen-binding (Fab) and fragment crystallizable (Fc) domains, predicting two distinct disease trajectory two days after a positive test.
The media should contribute to addressing tuberculosis in Ghana by disseminating information about TB transmission and encouraging the public to attend screenings, Frank Bonsu, program manager for the country's National Tuberculosis Control Program, said recently, Ghana Broadcasting Corporation reports. Bonsu spoke during a one-day TB advocacy workshop for media at the Korle-Bu Teaching Hospital in Accra.
› Verified 3 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164746392 PECOS PAC ID: 1951215243 Enrollment ID: O20040315000478 |
News Archive
Researchers at Caltech have developed a prototype miniature medical device that could ultimately be used in "smart pills" to diagnose and treat diseases.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
In a new study posted to the bioRxiv* preprint server, a prospective cohort of patients with COVID-19 exhibited distinct features of the IgG fragment antigen-binding (Fab) and fragment crystallizable (Fc) domains, predicting two distinct disease trajectory two days after a positive test.
The media should contribute to addressing tuberculosis in Ghana by disseminating information about TB transmission and encouraging the public to attend screenings, Frank Bonsu, program manager for the country's National Tuberculosis Control Program, said recently, Ghana Broadcasting Corporation reports. Bonsu spoke during a one-day TB advocacy workshop for media at the Korle-Bu Teaching Hospital in Accra.
› Verified 3 days ago
| Entity Name | Anmed Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427005727 PECOS PAC ID: 1951215243 Enrollment ID: O20040723000885 |
News Archive
Researchers at Caltech have developed a prototype miniature medical device that could ultimately be used in "smart pills" to diagnose and treat diseases.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
In a new study posted to the bioRxiv* preprint server, a prospective cohort of patients with COVID-19 exhibited distinct features of the IgG fragment antigen-binding (Fab) and fragment crystallizable (Fc) domains, predicting two distinct disease trajectory two days after a positive test.
The media should contribute to addressing tuberculosis in Ghana by disseminating information about TB transmission and encouraging the public to attend screenings, Frank Bonsu, program manager for the country's National Tuberculosis Control Program, said recently, Ghana Broadcasting Corporation reports. Bonsu spoke during a one-day TB advocacy workshop for media at the Korle-Bu Teaching Hospital in Accra.
› Verified 3 days ago
| Entity Name | South Carolina Dept Of Mental Health Accounting Office |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902476443 PECOS PAC ID: 9032021175 Enrollment ID: O20071217000080 |
News Archive
Researchers at Caltech have developed a prototype miniature medical device that could ultimately be used in "smart pills" to diagnose and treat diseases.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
In a new study posted to the bioRxiv* preprint server, a prospective cohort of patients with COVID-19 exhibited distinct features of the IgG fragment antigen-binding (Fab) and fragment crystallizable (Fc) domains, predicting two distinct disease trajectory two days after a positive test.
The media should contribute to addressing tuberculosis in Ghana by disseminating information about TB transmission and encouraging the public to attend screenings, Frank Bonsu, program manager for the country's National Tuberculosis Control Program, said recently, Ghana Broadcasting Corporation reports. Bonsu spoke during a one-day TB advocacy workshop for media at the Korle-Bu Teaching Hospital in Accra.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kara Kristin Cooper-gilmer, FNP 2000 E Greenville St, Suite 2800, Anderson, SC 29621-1580 Ph: (864) 512-7636 | Kara Kristin Cooper-gilmer, FNP 2000 E Greenville St Ste 2800, Anderson, SC 29621-1722 Ph: (864) 512-7636 |
News Archive
Researchers at Caltech have developed a prototype miniature medical device that could ultimately be used in "smart pills" to diagnose and treat diseases.
Aradigm Corporation announced today that it received the $4 million milestone payment from Zogenix, Inc. ("Zogenix") based upon the first commercial sale in the U.S. of SUMAVEL* DosePro* (sumatriptan injection) needle-free delivery system. The Company will receive quarterly royalty payments on all SUMAVEL DosePro sales. In 2006, the Company sold all assets related to the Intraject* needle-free injector technology (now rebranded as DosePro) to Zogenix in exchange for milestone and royalty payments.
In a new study posted to the bioRxiv* preprint server, a prospective cohort of patients with COVID-19 exhibited distinct features of the IgG fragment antigen-binding (Fab) and fragment crystallizable (Fc) domains, predicting two distinct disease trajectory two days after a positive test.
The media should contribute to addressing tuberculosis in Ghana by disseminating information about TB transmission and encouraging the public to attend screenings, Frank Bonsu, program manager for the country's National Tuberculosis Control Program, said recently, Ghana Broadcasting Corporation reports. Bonsu spoke during a one-day TB advocacy workshop for media at the Korle-Bu Teaching Hospital in Accra.
› Verified 3 days ago
Ning Sun, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4144 Clemson Blvd, Anderson, SC 29621 Phone: 864-224-9598 | |
Elizabeth Anne Stuart Whitman, FNP-BC, DNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 N Fant St, Anderson, SC 29621 Phone: 864-512-2000 | |
Jennifer P Arnett, PMHNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2000 E Greenville St, Anderson, SC 29621 Phone: 864-512-1000 | |
Lacey Wilbanks, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 108 Montgomery Dr, Anderson, SC 29621 Phone: 864-225-5597 | |
Sarah Browne Long, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2000 E Greenville St, Ste 3850, Anderson, SC 29621 Phone: 864-225-5667 Fax: 864-716-6158 | |
Cynthia Marie Petermann, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2001 E Greenville St, Anderson, SC 29621 Phone: 864-332-3098 Fax: 855-232-3959 | |
Mrs. Jennifer Lingerfelt, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4120 Highway 24, Anderson, SC 29626 Phone: 864-224-4003 |